shelf life on lilly tirzepatide says weight loss drug cuts heart failure risk by 38% in trial Zepbound (Tirzepatide) for Chronic Weight

10.3171/2023.8.Spine23427 40

The decreased proliferative ability of the ADSCs can affect the response to oxidative damage, the production of cytokines and the activity of fibroblasts

Brand-name tirzepatide (Mounjaro, Zepbound) Eli Lilly manufactures brand-name tirzepatide in prefilled injection pens with extensive stability testing

Additional References FDAs Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S

As the demand for innovative, effective treatments for diabetes and obesity continues to rise, the GLP-1 market is expected to expand further, with new drug approvals and improved treatment options likely to drive continued success